Toxicity profile of high dose methotrexate (HD-MTX) in osteosarcoma (OS) patients

被引：0
|
作者：
Samur, M [1 ]
Parrir, A [1 ]
Arican, A [1 ]
Sencan, O [1 ]
机构：
[1] Ankara Univ, Fac Med, Dept Med Oncol, TR-06100 Ankara, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP164
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [31] UTILIZING A MULTIDISCIPLINARY APPROACH TO DECREASE ERRORS RELATED TO HIGH-DOSE METHOTREXATE (HD-MTX) ON A HEMATOLOGY/ONCOLOGY INPATIENT UNIT
    Marsh, Kristen
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [32] Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 243 Non-Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India
    Bajpai, J.
    Talreja, V.
    Karpe, A.
    Rekhi, B.
    Vora, T.
    Banavali, S.
    Gupta, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S67 - S67
  • [33] High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Holmboe, Laila
    Andersen, Anders M.
    Morkrid, Lars
    Slordal, Lars
    Hall, Kirsten Sundby
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) : 106 - 114
  • [34] EFFECT OF INTRAVENOUS HIGH-DOSE METHOTREXATE (IV HD-MTX) ON REGIONAL CEREBRAL GLUCOSE METABOLIC-RATE (RCMRGLU) IN THE RAT
    PHILLIPS, P
    ALLEN, J
    ROTTENBERG, DA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 371 - 371
  • [35] HIGH-DOSE METHOTREXATE (HD-MTX) WITH CITROVORUM FACTOR (CF) RESCUE IN UNDIFFERENTIATED LARGE CELL-CARCINOMA (LCC) OF THE LUNG
    BHASKAR, B
    SHEEHY, PF
    SLATER, LM
    ARMENTROUT, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 110 - 110
  • [36] PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
    Schaff, Lauren
    Lobbous, Mina
    Bozza, Alexis
    Carlow, Dean
    Nabors, Louis
    Grommes, Christian
    NEURO-ONCOLOGY, 2020, 22 : 25 - 26
  • [37] DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE (HD-MTX) INFUSION - EVALUATION OF THE CLASSICAL TEST-DOSE (TD) PROTOCOL AND BAYESIAN-ESTIMATION (BE) IMPROVEMENTS
    BRUNO, R
    IMBERT, AM
    ILIADIS, A
    FAVRE, R
    LENA, N
    CATALIN, J
    CARCASSONNE, Y
    CANO, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 184 - 184
  • [38] High-dose methotrexate (HD-MTX) as CNS prophylaxis significantly improves outcome in patients with high-risk diffuse large B-cell lymphoma (DLBCL)
    Calimeri, T.
    Cecchetti, C.
    Vignati, A.
    Sassone, M.
    Foppoli, M.
    Scarfo, L.
    Ponzoni, M.
    Ferreri, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX)
    Twist, C. J.
    Kjelson, L.
    McKenney, A.
    Bonham, C. A.
    Esquivel, C.
    Castillo, R. O.
    XI INTERNATIONAL SMALL BOWEL TRANSPLANT SYMPOSIUM, 2009, : 116 - 121
  • [40] Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
    Abe, Kentaro
    Maeda-Minami, Ayako
    Ishizu, Taku
    Iwata, Shintaro
    Kobayashi, Eisuke
    Shimoi, Tatsunori
    Kawano, Yohei
    Hashimoto, Hironobu
    Yamaguchi, Masakazu
    Furukawa, Tetsuya
    Miyazaki, Satoru
    Mano, Yasunari
    ANTICANCER RESEARCH, 2022, 42 (02) : 1043 - 1050
12345